9 patents
Utility
Cannabinoid Conjugate Molecules
21 Sep 23
Disclosed are conjugate molecules formed from an active agent which is linked to a cannabinoid moiety through a specified linker having ester and amide end groups.
Paul M. Hershberger, Yinghui Liu, Kirk William Hering, James Bernard Kramer, Ramanathan S. Lalgudi
Filed: 8 Nov 22
Utility
Compositions for Topical Treatment of Radiation Dermatitis
17 Aug 23
The present disclosure relates to topical compositions and methods for the treatment of radiation dermatitis.
Purnendu Kumar Sharma, Alon Mantel, Srikanth Manne, Vijendra Nalamothu, Ramanathan Lalgudi
Filed: 8 Nov 22
Utility
Cannabinoid Conjugate Molecules
17 Aug 23
Disclosed are conjugate molecules formed from an active agent which is linked to a cannabinoid moiety through a specified linker having ester and amide end groups.
Paul M. Hershberger, Yinghui Liu, Kirk William Hering, James Bernard Kramer
Filed: 21 Apr 23
Utility
Cannabinoid Conjugate Molecules
17 Aug 23
Disclosed are conjugate molecules formed from an active agent which is linked to a cannabinoid moiety through a specified linker having ester and amide end groups.
Paul M. Hershberger, Yinghui Liu, Kirk William Hering, James Bernard Kramer, Ramanathan S. Lalgudi
Filed: 21 Apr 23
Utility
Cannabinoid conjugate molecules
30 May 23
Disclosed are conjugate molecules formed from an active agent which is linked to a cannabinoid moiety through a specified linker having ester and amide end groups.
Paul M. Hershberger, Yinghui Liu, Kirk William Hering, James Bernard Kramer, Ramanathan S. Lalgudi
Filed: 8 Nov 22
Utility
Compositions for Topical Treatment of Radiation Dermatitis
9 Feb 23
The present disclosure relates to topical compositions and methods for the treatment of radiation dermatitis.
Stella K. Vnook, Daniel J. Kaline, Ramanathan Lalgudi
Filed: 20 Jul 22
Utility
Administration Regimes of Cannabinoids In Combination with Chemotherapeutics Against Cancer
17 Nov 22
The present invention in the field of cancer therapeutics is based on the finding that when cannabinoids are administered to cancer subjects after a chemotherapeutic agent has been administered, the combined treatment leads to increased survival prognosis, a reduction in disease progression, stabilisation of disease state and inhibition of tumour growth than administration of the chemotherapeutic agent alone.
Wai Liu, Angus Dalgleish, Nadine Hall
Filed: 9 Aug 19
Utility
Compositions Comprising Cannabidiol and Second Therapeutic Agents for the Treatment of Cancer
24 Feb 22
The invention provides synergistic combinations of cannabidiol (CBD) and a second therapeutic agent, such as one or more ChEH/AEBS inhibitors, a naphthoquinone or a derivative thereof, or any combination thereof, effective for the treatment cancer.
Ilana NATHAN, Zvi VOGEL, Lakshmi Narasaiah UPPALAPATI, Adela Juknat GERALNIK
Filed: 28 Jul 21
Utility
Compositions comprising cannabidiol and second therapeutic agents for the treatment of cancer
17 Aug 21
The invention provides synergistic combinations of cannabidiol (CBD) and a second therapeutic agent, such as one or more ChEH/AEBS inhibitors, a naphthoquinone or a derivative thereof, or any combination thereof, effective for the treatment cancer.
Ilana Nathan, Zvi Vogel, Lakshmi Narasaiah Uppalapati, Adela Juknat Geralnik
Filed: 27 Oct 16
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first